0001576427-18-000092.txt : 20181113 0001576427-18-000092.hdr.sgml : 20181113 20181113172944 ACCESSION NUMBER: 0001576427-18-000092 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181108 FILED AS OF DATE: 20181113 DATE AS OF CHANGE: 20181113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mesrobian Edmond CENTRAL INDEX KEY: 0001639494 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36153 FILM NUMBER: 181179327 MAIL ADDRESS: STREET 1: 10 S ALMADEN BLVD STREET 2: 16TH FLOOR CITY: SAN JOSE STATE: CA ZIP: 95113 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Criteo S.A. CENTRAL INDEX KEY: 0001576427 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-ADVERTISING AGENCIES [7311] IRS NUMBER: 000000000 STATE OF INCORPORATION: I0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 32 RUE BLANCHE CITY: PARIS STATE: I0 ZIP: 75009 BUSINESS PHONE: 33140402290 MAIL ADDRESS: STREET 1: 32 RUE BLANCHE CITY: PARIS STATE: I0 ZIP: 75009 4 1 wf-form4_154214816687301.xml FORM 4 X0306 4 2018-11-08 0 0001576427 Criteo S.A. CRTO 0001639494 Mesrobian Edmond C/O CRITEO LEGAL DEPT. 387 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10016 1 0 0 0 Non-employee Warrant (right to buy) 22.45 2018-11-08 4 A 0 25000 7.87 A 2028-10-25 Ordinary Shares 25000.0 25000 D The exercise price of the non-employee warrant is 19.71 Euros. The U.S. dollar equivalent of the exercise price is $22.45 using the European Central Bank rate as of October 24, 2018 (1.00 = $1.1389), the date that is one business day prior to the date on which the issuer's board of directors determined the exercise price of the non-employee warrants. One-fourth of the grant will vest on October 25, 2019 and an additional 1/16th of the grant will vest quarterly thereafter. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The subscription price of the non-employee warrant is $7.87. The subscription price was satisfied by offset from fees otherwise paid to the reporting person by the issuer for service as a director. /s/ Ryan Damon, as attorney-in-fact for Edmond Mesrobian 2018-11-13